Filing Details

Accession Number:
0000899243-18-004482
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-20 06:09:57
Reporting Period:
2018-02-15
Accepted Time:
2018-02-20 06:09:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1160308 Savara Inc SVRA Pharmaceutical Preparations (2834) 841318182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1703487 N Robert Neville 900 S. Capital Of Texas Highway
Suite 150
Austin TX 78746
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-02-15 15,524 $12.84 414,861 No 4 S Direct
Common Stock Disposition 2018-02-15 9,476 $13.08 405,385 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.
  2. The price reported is a weighted average sale price. The sale prices ranged from $12.21 to $12.99 per share.
  3. The price reported is a weighted average sale price. The sale prices ranged from $13.00 to $13.71 per share.